Reuters.com – Study has been released show that middle aged men who used to take an aspirin or other type of Non Steroidal Anti-inflamatory drugs group, have significantly lower the protein level in the blood which use to indicate the prostate cancer in lab. Than men who don’t.
The study discussed that this may delay the early diagnosis of the cancer by lowering the PSA level “below the level of clinical suspicion,” Dr. Jay H. Fowke from Vanderbilt University in Nashville noted in a briefing with reporters Sunday. PSA stands for prostate-specific antigen.
A PSA test is used widely as a method to screen men for the possibility of prostate cancer, with higher blood PSA levels suggesting a greater chance of having prostate cancer.
Fowke and his associates collected data from more than 1,200 men older than 40 years who were referred for a biopsy of the prostate. Roughly 46 percent of the men reported taking an NSAID, primarily aspirin.
“These results may suggest that aspirin use decreases the ability to detect prostate cancer and may contribute to prior investigations reporting a protective association between NSAID use and prostate cancer risk,” Fowke and colleagues wrote.
